The ambition is to offer the market innovative analyses via Point-Of-careTesting (POCT), with the same high precision as hospitals' central laboratory, but with shortened analysis time.
The global market for POCT continues to grow. The POCT area as a whole had sales of $ 19.3 billion in 2018, and is expected to increase to $ 25.5 billion in 2023.
The global market for heart markers totalled $ 6.3 billion in 2017, and is expected to increase to $ 9.9 billion in 2022.
The Troponin market amounted to $ 2.3 billion in 2017, and is expected to increase to $ 3.6 billion in 2022. This corresponds to an average annual growth of 8.9%, which is one of the highest growth figures in the global POCT market.
1Point-of-care Diagnostics: Technologies and Global Markets, BBC Research, August 2019.
2 Cardiac Blomarkers: Technologies and Global Markets BBC Research, August 2019.
A significant need has been expressed for tests that are fast, accurate and can be performed close to patient - Point-Of-Care Testing (POCT). The market demands that more tests be moved away from large hospital labs, closer to the patient and treating caregivers, which has become even more visible during the corona pandemic. The need for safe, precise and high quality POCTs will thereby increase.